{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:46:35Z","timestamp":1789429595654,"version":"build-2803163510"},"reference-count":45,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Central precocious puberty (CPP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To summarize the available supporting evidence for the Endocrine Society guidelines about the management of CPP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Multiple databases (MEDLINE, EMBASE, Scopus) were searched to identify studies that addressed the Endocrine Society Guideline Development Panel's 10 clinical questions. Identified studies were selected and appraised, and data were extracted by pairs of independent trained reviewers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The systematic review yielded 3796 citations, of which 32 citations were included. The systematic review and meta-analysis demonstrate that in children with CPP, with no central nervous system symptoms, the rate of magnetic resonance imaging identification of pathogenic lesions (ie, hamartomas and brain tumors) was 6% (35 noncomparative studies with 5541 children with CPP). For girls with idiopathic CPP, gonadotropin-releasing hormone agonist (GnRHa) treatment was associated with +2.7 cm adult height gain compared to those who did not receive treatment (21 comparative observational studies with 1835 girls [mean age 8.20 \u00b1 1.08 years]). The review did not identify any studies that assessed the clinical questions on: benefits of additional evaluation in cases of early thelarche, differentiation of slowly vs rapidly progressing CPP, order of biochemical testing to establish and monitor the diagnosis of CPP, genetic testing for individuals diagnosed with CPP, and chronological age and\/or bone age for discontinuation of GnRHa treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This systematic review addresses various aspects of CPP evaluation and treatment of CPP and will support the development of the Endocrine Society guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag169","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:18:48Z","timestamp":1776511128000},"page":"2145-2153","source":"Crossref","is-referenced-by-count":5,"title":["A systematic review supporting the Endocrine Society clinical practice guidelines on central precocious puberty"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-624X","authenticated-orcid":false,"given":"Mohammed","family":"Firwana","sequence":"first","affiliation":[{"name":"Evidence-Based Practice Center, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Ramachandran","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Center, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel Kabbara","family":"Allababidi","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Center, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E","family":"Billstein","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Center, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal P","family":"Shah","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Center, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya Sai Sri","family":"Bandi","sequence":"additional","affiliation":[{"name":"Knowledge and Evaluation Research Unit (KER), Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhangi","family":"Bagewadi","sequence":"additional","affiliation":[{"name":"Knowledge and Evaluation Research Unit (KER), Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh Taki","family":"Aldin","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Center, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayla Shamsi","family":"Basha","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Center, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0559-8836","authenticated-orcid":false,"given":"Alaa","family":"Al Nofal","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Department of Pediatrics, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J","family":"Prokop","sequence":"additional","affiliation":[{"name":"Mayo Clinic Libraries, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6782-693X","authenticated-orcid":false,"given":"Ana Claudia","family":"Latronico","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Clinical Hospital, S\u00e3o Paulo Medical School, University of S\u00e3o Paulo , S\u00e3o Paulo 05403 900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2811-1322","authenticated-orcid":false,"given":"Stephanie A","family":"Roberts","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Boston Children's Hospital , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5502-5975","authenticated-orcid":false,"given":"M Hassan","family":"Murad","sequence":"additional","affiliation":[{"name":"Evidence-Based Practice Center, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]},{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic , Rochester, MN 55901 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"4","key":"2026081111270656700_dgag169-B1","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1542\/peds.104.4.936","article-title":"Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and therapeutics and executive committees of the lawson wilkins pediatric endocrine society","volume":"104","author":"Kaplowitz","year":"1999","journal-title":"Pediatrics"},{"issue":"4","key":"2026081111270656700_dgag169-B2","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2019.5881","article-title":"Worldwide secular trends in age at pubertal onset assessed by breast development among girls: a systematic review and meta-analysis","volume":"174","author":"Eckert-Lind","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"3","key":"2026081111270656700_dgag169-B3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S2213-8587(15)00380-0","article-title":"Causes, diagnosis, and treatment of central precocious puberty","volume":"4","author":"Latronico","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2026081111270656700_dgag169-B4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/endrev\/bnac020","article-title":"The congenital and acquired mechanisms implicated in the etiology of central precocious puberty","volume":"44","author":"Brito","year":"2023","journal-title":"Endocr Rev"},{"issue":"6","key":"2026081111270656700_dgag169-B5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/ejendo\/lvae063","article-title":"The genetic etiology is a relevant cause of central precocious puberty","volume":"190","author":"Canton","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2026081111270656700_dgag169-B6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S2352-4642(23)00237-7","article-title":"Central precocious puberty: a review of diagnosis, treatment, and outcomes","volume":"7","author":"Zevin","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"issue":"Suppl 2","key":"2026081111270656700_dgag169-B7","first-page":"33","article-title":"A critical appraisal of the effect of gonadotropin-releasing hormon analog treatment on adult height of girls with central precocious puberty","volume":"9","author":"Bereket","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2026081111270656700_dgag169-B8","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026081111270656700_dgag169-B9","doi-asserted-by":"crossref","unstructured":"Firwana M, Ramachandran N, Allababidi AK, et al \u00a0Supplementary material for \u201cA Systematic Review Supporting the Endocrine Society Clinical Practice Guidelines on Central Precocious Puberty\u201d. Figshare. 2026. 10.6084\/m9.figshare.31956231.v1","DOI":"10.1210\/clinem\/dgag169"},{"key":"2026081111270656700_dgag169-B10","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026081111270656700_dgag169-B11","first-page":"603","article-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of case-control studies in meta-analyses","volume":"25","author":"Wells","year":"2011","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"2026081111270656700_dgag169-B12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"Suppl 3","key":"2026081111270656700_dgag169-B13","first-page":"64","article-title":"Gonadotropin releasing hormone agonist treatment for central precocious puberty","volume":"51","author":"Carel","year":"1999","journal-title":"Horm Res"},{"issue":"3","key":"2026081111270656700_dgag169-B14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000456546","article-title":"Metabolic outcomes, bone health, and risk of polycystic ovary syndrome in girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogues","volume":"87","author":"Faienza","year":"2017","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"2026081111270656700_dgag169-B15","doi-asserted-by":"crossref","first-page":"dgz027","DOI":"10.1210\/clinem\/dgz027","article-title":"Long-term outcomes of treatments for central precocious puberty or early and fast puberty in Chinese girls","volume":"105","author":"Fu","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl","key":"2026081111270656700_dgag169-B16","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.12701\/jyms.2023.00801","article-title":"Adult height in girls with central precocious puberty without gonadotropin-releasing hormone agonist treatment: a retrospective case-control study","volume":"40","author":"Jang","year":"2023","journal-title":"J Yeungnam Med Sci"},{"issue":"2","key":"2026081111270656700_dgag169-B17","first-page":"54","article-title":"Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method","volume":"47","author":"Kauli","year":"1997","journal-title":"Horm Res"},{"issue":"2","key":"2026081111270656700_dgag169-B18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.14740\/jocmr3710","article-title":"The gonadotropin-releasing hormone analogue therapy may not impact final height in precocious puberty of girls with onset of puberty aged 6\u20148 years","volume":"11","author":"Korkmaz","year":"2019","journal-title":"J Clin Med Res"},{"issue":"4","key":"2026081111270656700_dgag169-B19","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1210\/jc.2014-3748","article-title":"Treated and untreated women with idiopathic precocious puberty: BMI evolution, metabolic outcome, and general health between third and fifth decades","volume":"100","author":"Lazar","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026081111270656700_dgag169-B20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/cen.12319","article-title":"Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades","volume":"80","author":"Lazar","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2026081111270656700_dgag169-B21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/jc.2009-0793","article-title":"The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study","volume":"95","author":"Magiakou","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026081111270656700_dgag169-B22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/jc.2007-1216","article-title":"Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function","volume":"93","author":"Pasquino","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026081111270656700_dgag169-B23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/09513590.2010.507289","article-title":"Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment","volume":"27","author":"Poomthavorn","year":"2011","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"2026081111270656700_dgag169-B24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000542038","article-title":"Adult height in girls with central precocious puberty with onset after 6 years: effects of gonadotropin-releasing hormone analog therapy","volume":"99","author":"Saito","year":"2026","journal-title":"Horm Res Paediatr"},{"issue":"11","key":"2026081111270656700_dgag169-B25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.15537\/smj.2017.11.21187","article-title":"Effect of gonadotropin-releasing hormone analogue on final adult height among Jordanian children with precocious puberty","volume":"38","author":"Swaiss","year":"2017","journal-title":"Saudi Med J"},{"issue":"1","key":"2026081111270656700_dgag169-B26","doi-asserted-by":"crossref","first-page":"31814","DOI":"10.1038\/s41598-025-02740-2","article-title":"The efficacy and safety of pharmacotherapy for girls with central precocious puberty or early normal puberty: a retrospective cohort study","volume":"15","author":"Yang","year":"2025","journal-title":"Sci Rep"},{"issue":"12","key":"2026081111270656700_dgag169-B27","doi-asserted-by":"crossref","first-page":"e3936","DOI":"10.1210\/clinem\/dgaf427","article-title":"Central precocious puberty in males, GnRH analog treated or untreated, did not impact fertility and health in midadulthood","volume":"110","author":"Lazar","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026081111270656700_dgag169-B28","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jpeds.2011.05.036","article-title":"A randomized trial of 1- and 3-month depot leuprolide doses in the treatment of central precocious puberty","volume":"159","author":"Fuld","year":"2011","journal-title":"J Pediatr"},{"issue":"5","key":"2026081111270656700_dgag169-B29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s11596-006-0519-2","article-title":"Efficacy of subcutaneous administration of gonadotropin-releasing hormone agonist on idiopathic central precocious puberty","volume":"26","author":"Liang","year":"2006","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"5","key":"2026081111270656700_dgag169-B30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2265.2009.03584.x","article-title":"Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: preliminary results","volume":"71","author":"Mericq","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 2","key":"2026081111270656700_dgag169-B31","first-page":"297","article-title":"Central precocious puberty: short-term comparative data of treatment with monthly or long-acting three months depot triptorelin","volume":"20","author":"Bertelloni","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7","key":"2026081111270656700_dgag169-B32","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.nurpra.2015.05.001","article-title":"Treatment of central precocious puberty using gonadotropin-releasing hormone agonists","volume":"11","author":"Cafasso","year":"2015","journal-title":"J Nurse Pract"},{"issue":"34","key":"2026081111270656700_dgag169-B33","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.3346\/jkms.2021.36.e219","article-title":"Efficacy of triptorelin 3-month depot compared to 1-month depot for the treatment of Korean girls with central precocious puberty in single tertiary center","volume":"36","author":"Chung","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"3","key":"2026081111270656700_dgag169-B34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.6065\/apem.2040134.067","article-title":"Short-term efficacy of 1-month and 3-month gonadotropin-releasing hormone agonist depots in girls with central precocious puberty","volume":"26","author":"Jeon","year":"2021","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"3","key":"2026081111270656700_dgag169-B35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.6065\/apem.2346132.066","article-title":"Long-term efficacy of a triptorelin 3-month depot in girls with central precocious puberty","volume":"29","author":"Park","year":"2024","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"2026081111270656700_dgag169-B36","doi-asserted-by":"crossref","first-page":"1390674","DOI":"10.3389\/fendo.2024.1390674","article-title":"Effectiveness of leuprolide acetate administered monthly compared to three-monthly in the treatment of central precocious puberty: evaluation at the end of treatment","volume":"15","author":"Thaneetrakool","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026081111270656700_dgag169-B37","first-page":"1043293","article-title":"Efficacy of leuprorelin 3-month depot (11.25 mg) compared to 1-month depot (3.75 mg) for central precocious puberty in Chinese girls: a prospective cohort study","volume":"2022","author":"Yang","year":"2022","journal-title":"International Journal of Endocrinology Print"},{"issue":"1","key":"2026081111270656700_dgag169-B38","first-page":"1264","article-title":"Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty","volume":"13","author":"Cho","year":"2023","journal-title":"Sci (Basel)"},{"issue":"4","key":"2026081111270656700_dgag169-B39","first-page":"175","article-title":"Age at menarche and near final height after treatment with gonadotropin-releasing hormone agonist alone or combined with growth hormone in Korean girls with central precocious puberty","volume":"24","author":"Gyon","year":"2015","journal-title":"Clin"},{"issue":"4","key":"2026081111270656700_dgag169-B40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.6065\/apem.2014.19.4.214","article-title":"Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone","volume":"19","author":"Jung","year":"2014","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"2","key":"2026081111270656700_dgag169-B41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.6065\/apem.2019.24.2.116","article-title":"Comparing adult height gain and menarcheal age between girls with central precocious puberty treated with gonadotropin-releasing hormone agonist alone and those treated with combined growth hormone therapy","volume":"24","author":"Kim","year":"2019","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"7-8","key":"2026081111270656700_dgag169-B42","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1515\/jpem-2014-0305","article-title":"Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty","volume":"28","author":"Liang","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7","key":"2026081111270656700_dgag169-B43","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1515\/JPEM.2003.16.7.1005","article-title":"Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution","volume":"16","author":"Pucarelli","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"Suppl","key":"2026081111270656700_dgag169-B44","first-page":"811","article-title":"Combined therapy with GnRH analog plus growth hormone in central precocious puberty","volume":"13","author":"Pucarelli","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2026081111270656700_dgag169-B45","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1662808","article-title":"Efficacy of combined gonadotropin-releasing hormone analogue and growth hormone therapy in girls with central precocious puberty: a systematic review and meta-analysis","volume":"16","author":"Jin","year":"2025","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag169\/68424269\/dgag169.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/8\/2145\/68424269\/dgag169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/8\/2145\/68424269\/dgag169.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:44:46Z","timestamp":1786463086000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/8\/2145\/8697369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,6,13]]},"published-print":{"date-parts":[[2026,7,15]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag169","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,6,13]]}}}